PRKCE and prostate carcinoma: Studies revealed that ectopic expression of PKCε in LNCaP prostate cancer cells stimulates proliferation, and upregulates cyclins D1, D3, and E. PKCε overexpression also causes a discernible upregulation in E2F-1 and c-myc, an oncogene with functional E2F binding sites in its promoter.